Furosemide Oral Solution shortage
Current 3 presentations · 1 manufacturers · first FDA posting 2026-03-31 · last update 2026-10-14
Manufacturers: Hikma Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Shortage of an inactive ingredient component
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/31/2026 Updated 10/14/2026 | |
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an inactive ingredient component | Available on allocation | Posted 03/31/2026 Updated 10/14/2026 |
| Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Hikma Pharmaceuticals USA, Inc. | Current Available |
Shortage of an inactive ingredient component | Posted 03/31/2026 Updated 10/14/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)